Blog Viewer

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study

By Currents Editor posted 03-23-2022 11:57

  

Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study
Stroke (02/10/22) DOI: 10.1161/STROKEAHA.121.037541
Yaghi, Shadi; Shu, Liqi; Bakradze, Ekaterina; et al.

https://www.ahajournals.org/doi/10.1161/STROKEAHA.121.037541 

An international retrospective study compared direct oral anticoagulants (DOACs) with warfarin in a real-world cerebral venous thrombosis (CVT) cohort. The study included 845 patients with CVT who received oral anticoagulants from January 2015 through December 2020. Among the patients, 33.0% received DOACs, 51.8% received warfarin, and 15.1% received both treatments at different times. In all, there were 5.68 recurrent thromboses, 3.77 major hemorrhages, 1.84 deaths per 100 patient-years over a median follow-up of 345 days. For the 525 patients who met the recanalization analysis inclusion criteria, 36.6% had complete recanalization, 48.2% had partial, and 15.2% had no recanalization. Overall, treatment with DOACs had a similar risk of recurrent venous thrombosis, death, and rate of partial/complete recanalization compared with warfarin; however, there was a lower risk of major hemorrhage with DOACs. Large prospective or randomized studies are needed to confirm these findings, the authors conclude.

#LiteratureWatch

FURTHER READING
Michelle Schober, MD, MS Audrey Paulson, DNP, FNP-BC, CCRN, CNRN, SCRN Ethical principles common to the various health care professions include the concepts of justice, nonmaleficence, beneficence, and autonomy. The American Nurses Association (ANA) Code contains these concepts and cites three additional ...
New England Journal of Medicine (10/20/22) DOI: 10.1056/NEJMoa2208687 Kjaergaard, Jesper; Møller, Jacob E.; Schmidt, Henrik; et al. https://www.nejm.org/doi/full/10.1056/NEJMoa2208687 For patients who had been resuscitated from cardiac arrest, targeting a mean arterial blood pressure of 77 mm Hg ...
By Sarah Livesay, DNP, APRN Associate Dean, Rush University, President NCS Mary Kay Bader, RN, MSN, Neurocritical Care CNS, Mission Hospital Mission Viejo CA, Past President NCS Karen Hirsch MD, Associate Professor of Neurology, Division Chief Neurocriticial Care, Stanford University Romer Geocadin ...